News Detail
New Delhi, 26 Feb 2025: Indian drugmakers are likely to remain competitive in the generics market in the face of US President Donald Trump's plans to levy tariffs on pharmaceutical imports, Dr Reddy's Managing Director GV Prasad said on Tuesday.
Trump has said he could......
View Details
Source : Reuters
Indian drugmakers on tariffs
Dr Reddy
Indian drugmakers tariffs
GV Prasad Dr Reddy
pharma exports
Indian pharma exports
Indian drugmakers on US tariffs
Related News
- Will the Centre compensate for adverse Covid vaccine effects? SC seeks govt reply on framing policy (26-02-2025)
- Regulatory standards must be stronger for quality medicines: Health secy (26-02-2025)
- CDSCO asks State drug regulators to keep vigil against use of nimesulide in animals (26-02-2025)
- Ensure no prescription drugs sold illegally, HC directs CBI, NCB (25-02-2025)
- Drugs & Cosmetics Act: Only Sessions Court Can Try Offences Punishable Under Chapter IV (25-02-2025)
- SC calls for mechanism under law for misleading ads complaints (25-02-2025)
- Maharashtra Medical Council Launches ‘Know Your Doctor’ Platform to Curb quackery (25-02-2025)
- 3 in 5 individuals in India die after cancer diagnosis: Study (25-02-2025)
- International Vaccine Institute launches new biorepository in South Korea (25-02-2025)
- MoU signed for inter-ministerial cooperation for promotion of 'One Herb, One Standard' (25-02-2025)